Mirae Asset Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $64.4M | Buy |
|
|||||
2025
Q1 | $69.5M | Buy |
|
|||||
2024
Q4 | $48.4M | Buy |
|
|||||
2024
Q3 | $47.3M | Buy |
|
|||||
2024
Q2 | $43.6M | Sell |
|
|||||
2024
Q1 | $105M | Buy |
|
|||||
2023
Q4 | $121M | Sell |
|
|||||
2023
Q3 | $111M | Buy |
|
|||||
2023
Q2 | $97.7M | Sell |
|
|||||
2023
Q1 | $89.8M | Sell |
|
|||||
2022
Q4 | $88.3M | Sell |
|
|||||
2022
Q3 | $92.7M | Sell |
|
|||||
2022
Q2 | $94.6M | Buy |
|
|||||
2022
Q1 | $84.7M | Buy |
|
|||||
2021
Q4 | $62.7M | Buy |
|
|||||
2021
Q3 | $45M | Buy |
|
|||||
2021
Q2 | $34.2M | Sell |
|
|||||
2021
Q1 | $71.1M | Sell |
|
|||||
2020
Q4 | $121M | Buy |
|
|||||
2020
Q3 | $53.5M | Buy |
|
|||||
2020
Q2 | $50.9M | Sell |
|
|||||
2020
Q1 | $62.9M | Buy |
|
|||||
2019
Q4 | $19.1M | Buy |
|
|||||
2019
Q3 | $11M | Buy |
|
|||||
2019
Q2 | $10.4M | Buy |
|
|||||
2019
Q1 | $10.4M | Buy |
|
|||||
2018
Q4 | $8.93M | Buy |
|
|||||
2018
Q3 | $9.14M | Buy |
|
|||||
2018
Q2 | $5.61M | Buy |
|
|||||
2018
Q1 | $5.26M | Buy |
|
|||||
2017
Q4 | $4.39M | Sell |
|
|||||
2017
Q3 | $4.66M | Buy |
|
|||||
2017
Q2 | $2.66M | Buy |
|
|||||
2017
Q1 | $2.06M | Buy |
|
|||||
2016
Q4 | $363K | Sell |
|
|||||
2016
Q3 | $844K | Sell |
|
|||||
2016
Q2 | $885K | Sell |
|
|||||
2016
Q1 | $827K | Sell |
|
|||||
2015
Q4 | $2.79M | Buy |
|
|||||
2015
Q3 | $670K | Sell |
|
|||||
2015
Q2 | $838K | Buy |
|
|||||
2015
Q1 | $775K | Buy |
|
|||||
2014
Q4 | $639K | Buy |
|
|||||
2014
Q3 | $604K | Buy |
|
|||||
2013
Q3 | – | Sell |
|
|||||
2013
Q2 | $538K | Buy |
|